Skip to Main Content

Author Details

Florence M G Cavalli
Institut Curie, PSL Research University
2009
41
31
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37781087ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.Neurooncol Adv2023
34907396Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36185361Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma.iScience2022
33427645Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival.Elife2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33579912PRMT5 inhibition disrupts splicing and stemness in glioblastoma.Nat Commun2021
35122077Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity.Nat Cancer2021
34045740Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.Nat Med2021
32424282Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
31076851Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.Acta Neuropathol2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
31768071Stalled developmental programs at the root of pediatric brain tumors.Nat Genet2019
31185958Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.BMC Cancer2019
31328883An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.EMBO Mol Med2019
31249064High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.Genome Res2019
30995489Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.Cell Rep2019
30019219Heterogeneity within the PF-EPN-B ependymoma subgroup.Acta Neuropathol2018
28609654Intertumoral Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2017
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
28176486Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.Proteomics2017
28726821The whole-genome landscape of medulloblastoma subtypes.Nature2017
28854171Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.Nature2017
26760213Divergent clonal selection dominates medulloblastoma at recurrence.Nature2016
27269943Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.J Clin Oncol2016
27551116Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.J Clin Oncol2016
25689980Medulloblastoma subgroups remain stable across primary and metastatic compartments.Acta Neuropathol2015
24493713Cytogenetic prognostication within medulloblastoma subgroups.J Clin Oncol2014
25043047Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.Nature2014
24553142Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.Nature2014
23670100Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.Acta Neuropathol2013
24174164TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.Acta Neuropathol2013
23599465Response to Comments on "Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters".Science2013
22421046The MOF chromobarrel domain controls genome-wide H4K16 acetylation and spreading of the MSL complex.Dev Cell2012
23079654Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.Cancer Cell2012
22832581Subgroup-specific structural variation across 1,000 medulloblastoma genomes.Nature2012
22821985Drosophila dosage compensation involves enhanced Pol II recruitment to male X-linked promoters.Science2012
21204268Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.EMBO Mol Med2011
19332112Identification of expressed transposable element insertions in the sequenced genome of Drosophila melanogaster.Gene2009
  • 1 - 41 of 41

Recommended Authors

German Cancer Research Center (DKFZ)
Career Start Year 2018
Number of shared co-authors 26
St. Jude Children's Research Hospital
Career Start Year 2018
Number of shared co-authors 75
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 86
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 14
Institute of Pathology, Charite Universitatsmedizin Berlin
Career Start Year 2013
Number of shared co-authors 17
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 16
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2012
Number of shared co-authors 82
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 12
University of California san francisco
Career Start Year 2012
Number of shared co-authors 3
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 6
Hospital for Sick Children
Career Start Year 2011
Number of shared co-authors 19
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 84
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 31
INSERM U, PSL Research University, Institut Curie Research Center
Career Start Year 2006
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 15
University of Colorado Anschutz Medical Campus
Career Start Year 2004
Number of shared co-authors 4
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 28
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 35
University of California san francisco
Career Start Year 2003
Number of shared co-authors 59
St Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 40
Henry Ford Hospital
Career Start Year 2003
Number of shared co-authors 24
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 8
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 81
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 18
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 29
University of California san francisco
Career Start Year 1991
Number of shared co-authors 35
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 51

Collaborators

The Hospital for Sick Children
Co-authored papers 31
Hospital for Sick Children
Co-authored papers 23
The Hospital for Sick Children, University of Toronto
Co-authored papers 18
University of Wollongong
Co-authored papers 17
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 17
Cumming School of Medicine, University of Calgary
Co-authored papers 16
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 16
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 14
The Hospital for Sick Children
Co-authored papers 14
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 14
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 14
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 13
University of British Columbia
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 12
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 12
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 11
Dana-Farber Cancer Institute
Co-authored papers 11
Hospital for Sick Children
Co-authored papers 11
St Jude Children's Research Hospital
Co-authored papers 11
St Jude Children's Research Hospital
Co-authored papers 11
The Hospital for Sick Children
Co-authored papers 11
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 10
BioBox Analytics Inc.
Co-authored papers 10
Seoul National University Children's Hospital
Co-authored papers 10
University of California san francisco
Co-authored papers 10
Kitasato University School of Medicine
Co-authored papers 10
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 10
The Hospital for Sick Children
Co-authored papers 10